ROFECOXIB - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for rofecoxib and what is the scope of freedom to operate?

Rofecoxib is the generic ingredient in one branded drug marketed by Merck and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for rofecoxib.

Summary for ROFECOXIB

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	2
Drug Master File Entries:	2
Raw Ingredient (Bulk) Api Vendors:	115
Clinical Trials:	40
Patent Applications:	7,190
DailyMed Link:	ROFECOXIB at DailyMed

Recent Clinical Trials for ROFECOXIB

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tremeau Pharmceuticals, Inc.	Phase 3
University of Pennsylvania	Phase 1
National Heart, Lung, and Blood Institute (NHLBI)	Phase 1

See all ROFECOXIB clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ROFECOXIB

M01AH	Coxibs
M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M	Musculo-skeletal system

US Patents and Regulatory Information for ROFECOXIB

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Merck	VIOXX	rofecoxib	SUSPENSION;ORAL	021052-002	May 20, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-001	May 20, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-002	May 20, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Merck	VIOXX	rofecoxib	SUSPENSION;ORAL	021052-001	May 20, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ROFECOXIB

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-001	May 20, 1999	⤷ Sign Up	⤷ Sign Up
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-003	Feb 25, 2000	⤷ Sign Up	⤷ Sign Up
Merck	VIOXX	rofecoxib	SUSPENSION;ORAL	021052-001	May 20, 1999	⤷ Sign Up	⤷ Sign Up
Merck	VIOXX	rofecoxib	SUSPENSION;ORAL	021052-002	May 20, 1999	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.